Home » Authors » James Etheridge

Articles by James Etheridge

BioAlliance Gets Green Light For Phase II/III Transdrug Trial

Dec. 20, 2006

By James Etheridge

IntegraGen Setting Up U.S. Subsidiary For Diagnostics

Dec. 20, 2006

By James Etheridge

Trophos Announces Plans For ALS TRO19622 Phase II/III Trial

Dec. 13, 2006

By James Etheridge

Novexel Licenses Aminocandin From Indevus Pharmaceuticals

Dec. 13, 2006

By James Etheridge

Genfit To List Shares On Alternext Market In Paris

Dec. 13, 2006

By James Etheridge

Novexel Licenses Aminocandin From Indevus Pharmaceuticals

Dec. 13, 2006

By James Etheridge

Trophos Announces Plans For ALS TRO19622 Phase II/III Trial

Dec. 13, 2006

By James Etheridge

Genfit To List Shares On Alternext Market In Paris

Dec. 13, 2006

By James Etheridge

Biocortech, Servier To Work Together On CNS Disorders

Dec. 6, 2006

By James Etheridge

Biocortech, Servier To Work Together On CNS Disorders

Dec. 6, 2006

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...